3 Steps to Improved Health Outcomes

Philadelphia PA – On April 15-16, pharma industry leaders will convene in Philadephia to discuss how to best evolve the new commercial model to improve health outcomes.

2014 is shaping up to be be the year where pharma and their stakeholders join up to innovate and are able to redefine value in healthcare products and services.

Against that backdrop, eyeforpharma’s flagship summit takes place in Philadelphia on April 15-16 and focuses on three key strategic areas pharma companies need to employ to remain relevant and competitive in the new commercial landscape:

• Collaboration- Partner with stakeholders to deliver customer-centric values and improve health outcomes

As Kyle Dolbow, President of Vree Health stated in a recent interview with eyeforpharma, “When you look at outcomes focused health care, the interests of all parties are lined up, payers, providers, and of course, the patient. What you will see in the future is new alliances to affect patient results. I think the way the new models will succeed is through ecosystems that are acting together to improve the care. “

• Innovation- New approaches to encourage optimal patient outcomes and business results

“The ultimate goal of a ‘learning fast’ approach to innovation is to embed in your culture the ability to extract the key insights from your marketing efforts and the ability to quickly recognize how to modify your project plan to take advantage of unexpected learnings, and the flexibility and empowerment to make the necessary course corrections.” highlights Dave Moore, Cempra Therapeutics

• Technology- Utilize data analytics and technology to optimize engagement, promote efficiency and reduce costs

 “The cost of hospital readmissions is sizeable and it is currently estimated that one in five Medicare patients who are hospitalized will be readmitted within 30 days – that’s about 2 million people a year – and avoidable readmissions cost the government more than $17 billion annually. Technology can be a key enabler in this multi-faceted problem which requires a comprehensive approach to transitional care”, explains Chris Ellis, Marketing Director at Vree Health.

Kyle, Dave and Chris will be speaking at the 12th annual eyeforpharma Philadelphia event April 15-16, and will be joined by 60+ healthcare experts presenting across three tracks and over 30 conference sessions.

“Market transformation in recent years has redefined pharma, and the commercial model has rationalized to focus on the real bottom line - improving health outcomes. With this goal as its key theme, eyeforpharma Philadelphia 2014 looks set, once again to be the event that shapes the future of commercial pharma in the US”, said event director Evena Liao.

eyeforpharma Philadelphia is going into its 12th year and is the US’s most established meeting place for commercial pharma executives. For more information please go to:

http://www.eyeforpharma.com/philadelphia/index.php 

Contact:

Brittany Reyes
Marketing Director | eyeforpharma
breyes@eyeforpharma.com  

eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more. eyeforpharma is part of FC Business Intelligence Ltd. FC Business Intelligence Ltd is a registered company in England and Wales - Registered number 04388971, 7-9 Fashion Street, London, E1 6PX, UK.